What's breaking now, across thousands of outlets.
Adding the targeted radioactive drug 177Lu-PNT2002 to stereotactic body radiation therapy, or SBRT, may help keep recurrent prostate cancer under control longer than SBRT alone, according to new research led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center.
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.
Head and neck squamous cell carcinoma (HNSCC) frequently develops in the oral and upper aerodigestive regions following chronic exposure to mutagenic factors such as tobacco, alcohol and betel nut.
Mumbai: The Food and Drug Administration (FDA) has suspended the licences or registrations of three food establishments in Mumbai, including a Domino’s Pizza outlet in Parel, over serious food safety…
Beam's first data on a rare disease gene editing therapy: Beam Therapeutics shared initial data from a Phase 1/2 trial of a base editing therapy for glycogen storage disease type Ia ...
Doctors have a lot on the line in the next couple years, and they are donating big to doctors running for political office.
Mumbai: Nearly 150 children from underserved communities participated in an interactive learning programme on healthy habits organised by Abbott in partnership with Sesame Workshop India in Mumbai…
